Frankendal B - Search Results

1

2-DE protein expression in endometrial carcinoma.

Lundgren C, Lahmann J, Becker S, Roblick U, Schedvins K, Boman K, Frankendal B, Nordström B, Auer G. Lundgren C, et al. Among authors: frankendal b. Acta Oncol. 2006;45(6):685-94. doi: 10.1080/02841860600660787. Acta Oncol. 2006. PMID: 16938811

2

Prognostic factors in surgical stage I endometrial carcinoma.

Lundgren C, Auer G, Frankendal B, Nilsson B, Nordström B. Lundgren C, et al. Among authors: frankendal b. Acta Oncol. 2004;43(1):49-56. doi: 10.1080/02841860310018990. Acta Oncol. 2004. PMID: 15068320

3

Laminin-5 gamma2-chain expression and DNA ploidy as predictors of prognosis in endometrial carcinoma.

Lundgren C, Frankendal B, Silfverswärd C, Nilsson B, Tryggvason K, Auer G, Nordström B. Lundgren C, et al. Among authors: frankendal b. Med Oncol. 2003;20(2):147-56. doi: 10.1385/MO:20:2:147. Med Oncol. 2003. PMID: 12835517

4

Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma.

Lundgren C, Auer G, Frankendal B, Moberger B, Nilsson B, Nordström B. Lundgren C, et al. Among authors: frankendal b. Int J Gynecol Cancer. 2002 Jan-Feb;12(1):110-8. doi: 10.1046/j.1525-1438.2002.01079.x. Int J Gynecol Cancer. 2002. PMID: 11860545

5

Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study.

Sorbe B, Nordström B, Mäenpää J, Kuhelj J, Kuhelj D, Okkan S, Delaloye JF, Frankendal B. Sorbe B, et al. Among authors: frankendal b. Int J Gynecol Cancer. 2009 Jul;19(5):873-8. doi: 10.1111/IGC.0b013e3181a6c9df. Int J Gynecol Cancer. 2009. PMID: 19574776 Clinical Trial.

6

Preoperative intracavitary irradiation of endometrial carcinoma stage I by a high dose rate afterloading technique.

Sorbe B, Frankendal B, Risberg B. Sorbe B, et al. Among authors: frankendal b. Acta Oncol. 1989;28(4):577-82. doi: 10.3109/02841868909092274. Acta Oncol. 1989. PMID: 2789837

7

Cancer of the vagina: Laminin-5gamma2 chain expression and prognosis.

Hellman K, Hellström AC, Silfverswärd C, Salo S, Aspenblad U, Nilsson B, Frankendal B, Tryggvasson K, Auer G. Hellman K, et al. Among authors: frankendal b. Int J Gynecol Cancer. 2000 Sep;10(5):391-396. doi: 10.1046/j.1525-1438.2000.010005391.x. Int J Gynecol Cancer. 2000. PMID: 11240703

8

DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinoma.

Sorbe B, Risberg B, Frankendal B. Sorbe B, et al. Among authors: frankendal b. Gynecol Oncol. 1990 Jul;38(1):22-7. doi: 10.1016/0090-8258(90)90005-6. Gynecol Oncol. 1990. PMID: 2354822

9

S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix.

Strang P, Eklund G, Stendahl U, Frankendal B. Strang P, et al. Among authors: frankendal b. Anticancer Res. 1987 Jul-Aug;7(4B):807-10. Anticancer Res. 1987. PMID: 3674766

10

Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina.

Hellman K, Lundell M, Silfverswärd C, Nilsson B, Hellström AC, Frankendal B. Hellman K, et al. Among authors: frankendal b. Int J Gynecol Cancer. 2006 May-Jun;16(3):1201-11. doi: 10.1111/j.1525-1438.2006.00520.x. Int J Gynecol Cancer. 2006. PMID: 16803507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters